Nobukiyo Koide

702 total citations
19 papers, 574 citations indexed

About

Nobukiyo Koide is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Nobukiyo Koide has authored 19 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in Nobukiyo Koide's work include Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). Nobukiyo Koide is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). Nobukiyo Koide collaborates with scholars based in Japan. Nobukiyo Koide's co-authors include Tomokazu Oyama, Yoh Miyashita, Atsuhito Saiki, Kohji Shirai, Takeyoshi Murano, Kei Endo, Masahiro Ohira, Hiroshi Ozaki, Hitoshi Watanabe and M Ohtsuka and has published in prestigious journals such as International Journal of Obesity, Metabolism and Diabetes Research and Clinical Practice.

In The Last Decade

Nobukiyo Koide

18 papers receiving 556 citations

Peers

Countries citing papers authored by Nobukiyo Koide

Since Specialization

Citations

This map shows the geographic impact of Nobukiyo Koide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobukiyo Koide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobukiyo Koide more than expected).

Fields of papers citing papers by Nobukiyo Koide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobukiyo Koide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobukiyo Koide. The network helps show where Nobukiyo Koide may publish in the future.

Co-authorship network of co-authors of Nobukiyo Koide

This figure shows the co-authorship network connecting the top 25 collaborators of Nobukiyo Koide. A scholar is included among the top collaborators of Nobukiyo Koide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobukiyo Koide. Nobukiyo Koide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Pioglitazone Decreases Plasma Angiotensin II Concentration inType 2 Diabetes 2010 ·Journal of Atherosclerosis and Thrombosis ·Atsuhito Saiki, Masahiro Ohira, Kei Endo, Nobukiyo Koide, Tomokazu Oyama, Takeyoshi Murano, Yoh Miyashita, Kohji Shirai	7
2	Aseptic meningitis as the sole manifestation of Behçet’s disease 2009 ·Neurological Sciences ·Ryuji Sakakibara, Nobukiyo Koide, Masahiko Kishi, Emina Ogawa, Kohji Shirai	4
3	Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus 2009 ·Metabolism ·Atsuhito Saiki, Masahiro Ohira, Kei Endo, Nobukiyo Koide, Tomokazu Oyama, Takeyoshi Murano, Hitoshi Watanabe, Yoh Miyashita, Kohji Shirai	63
4	Determination of serum 7-ketocholesterol concentrations and their relationships with coronary multiple risks in diabetes mellitus 2008 ·Diabetes Research and Clinical Practice ·Kei Endo, Tomokazu Oyama, Atsuhito Saiki, Noriko Ban, Masahiro Ohira, Nobukiyo Koide, Takeyoshi Murano, Hitoshi Watanabe, (unknown), (unknown), (unknown), Yoh Miyashita, Koji Shirai	41
5	Suppression of lipoprotein lipase expression in 3T3-L1 cells by inhibition of adipogenic differentiation through activation of the renin-angiotensin system 2008 ·Metabolism ·Atsuhito Saiki, Nobukiyo Koide, (unknown), Takeyoshi Murano, Yoh Miyashita, Kohji Shirai	23
6	Effect of Acarbose, an Alpha-Glucosidase Inhibitor, on Serum Lipoprotein Lipase Mass Levels and Common Carotid Artery Intima-Media Thickness in Type 2 Diabetes Mellitus Treated by Sulfonylurea 2008 ·Journal of Atherosclerosis and Thrombosis ·Tomokazu Oyama, Atsuhito Saiki, (unknown), Noriko Ban, (unknown), (unknown), Nobukiyo Koide, Yoh Miyashita, Kohji Shirai	29
7	Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients 2007 ·Diabetes Research and Clinical Practice ·Masahiro Ohira, Yoh Miyashita, (unknown), Atsuhito Saiki, Kei Endo, Nobukiyo Koide, Tomokazu Oyama, Takeyoshi Murano, Hitoshi Watanabe, Kohji Shirai	28
8	Effects of Calorie-Restricted Low-Carbohydrate Diet on Glucose and Lipid Metabolism in Otsuka Long Evans Tokushima Fatty Rats 2007 ·Journal of Atherosclerosis and Thrombosis ·Nobukiyo Koide, Tomokazu Oyama, Yoh Miyashita, (unknown)	3
9	[The lipid metabolism in obesity]. 2007 ·PubMed ·Nobukiyo Koide, Kohji Shirai	0
10	The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension 2006 ·Diabetes Research and Clinical Practice ·Atsuhito Saiki, Masahiro Ohira, Kei Endo, Nobukiyo Koide, Tomokazu Oyama, Takeyoshi Murano, Yoh Miyashita, Kohji Shirai	14
11	Enhancement of serum lipoprotein lipase mass levels by intensive insulin therapy 2006 ·Diabetes Research and Clinical Practice ·Yoh Miyashita, (unknown), (unknown), (unknown), Atsuhito Saiki, Nobukiyo Koide, (unknown), Tomokazu Oyama, Kohji Shirai	7
12	Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome 2006 ·Diabetes Research and Clinical Practice ·Atsuhito Saiki, Tomokazu Oyama, Kei Endo, (unknown), Masahiro Ohira, Nobukiyo Koide, Takeyoshi Murano, Yoh Miyashita, Kohji Shirai	70
13	Probucol and Atorvastatin Decrease Urinary 8-Hydroxy-2'-deoxyguanosine in Patients with Diabetes and Hypercholesterolemia 2006 ·Journal of Atherosclerosis and Thrombosis ·Kei Endo, Yoh Miyashita, (unknown), (unknown), Masahiro Ohira, Atsuhito Saiki, Nobukiyo Koide, Tomokazu Oyama, Takeyoshi Murano, Koji Shirai	35
14	Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy 2005 ·International Journal of Obesity ·Atsuhito Saiki, (unknown), (unknown), (unknown), M Ohtsuka, Nobukiyo Koide, Tomokazu Oyama, Yasushi Miyashita, Keiko Shirai	92
15	Probucol delays progression of diabetic nephropathy 2005 ·Diabetes Research and Clinical Practice ·Kei Endo, Yoh Miyashita, (unknown), Masahiro Ohira, Atsuhito Saiki, Nobukiyo Koide, Masaki Otsuka, Tomokazu Oyama, Takeyoshi Murano, Yoshiaki Ito, Koji Shirai	34
16	Apoptosis Induced by 7-Ketocholesterol is Enhanced in Smooth Muscle Cells Derived from OLETF Rats 2005 ·Journal of Atherosclerosis and Thrombosis ·Yoh Miyashita, Nobukiyo Koide, Tomokazu Oyama, Yoshiaki Itoh, Kohji Shirai	3
17	Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity 2004 ·Diabetes Research and Clinical Practice ·Yoh Miyashita, Nobukiyo Koide, (unknown), Hiroshi Ozaki, Yoshiaki Itoh, Tomokazu Oyama, (unknown), (unknown), Kohji Shirai	64
18	Atorvastatin and Pravastatin Elevated Pre-heparin Lipoprotein Lipase Mass of Type 2 Diabetes with Hypercholesterolemia 2004 ·Journal of Atherosclerosis and Thrombosis ·Kei Endo, Yoh Miyashita, Atsuhito Saiki, Tomokazu Oyama, Nobukiyo Koide, Hiroshi Ozaki, Masaki Otsuka, Yoshiaki Ito, Kohji Shirai	38
19	Oxysterol-Induced Apoptosis of Vascular Smooth Muscle Cells is Reduced by HMG-CoA Reductase Inhibitor, Pravastatin 2002 ·Journal of Atherosclerosis and Thrombosis ·Yoh Miyashita, Hiroshi Ozaki, Nobukiyo Koide, Masaki Otsuka, Tomokazu Oyama, Yoshiaki Itoh, (unknown), Kohji Shirai	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact